Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity

Planning experiments: Updated guidance on experimental design and analysis and their reporting III

(2022) Michael J. Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Host Modulation and Treatment of Periodontal Disease

(2021) M.G. Balta et al.   JOURNAL OF DENTAL RESEARCH

Resolution of inflammation: An organizing principle in biology and medicine

(2021) Dipak Panigrahy et al.   PHARMACOLOGY & THERAPEUTICS

Resolvin E1 Regulates Th17 Function and T Cell Activation

(2021) Fatma Oner et al.   Frontiers in Immunology

RvE1 Impacts the Gingival Inflammatory Infiltrate by Inhibiting the T Cell Response in Experimental Periodontitis

(2021) Carla Alvarez et al.   Frontiers in Immunology

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Macrophages: The Good, the Bad, and the Gluttony

(2021) Ewan A. Ross et al.   Frontiers in Immunology

Targeting Soluble Epoxide Hydrolase and Cyclooxygenases Enhance Joint Pain Control, Stimulate Collagen Synthesis, and Protect Chondrocytes From Cytokine-Induced Apoptosis

(2021) Laura Tucker et al.   Frontiers in Veterinary Science

Clinical and preclinical evidence for roles of soluble epoxide hydrolase in osteoarthritis knee pain

(2021) Peter R. W. Gowler et al.   Arthritis & Rheumatology

Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?

(2020) Dipak Panigrahy et al.   CANCER AND METASTASIS REVIEWS

Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model

(2020) Carlos A. Trindade‐da‐Silva et al.   FASEB JOURNAL

Shifting the paradigm from inhibitors of inflammation to resolvers of inflammation in periodontitis

(2020) Thomas E. Van Dyke   JOURNAL OF PERIODONTOLOGY

Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing

(2020) Miguel Quiros et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Nexus Between Periodontal Inflammation and Dysbiosis

(2020) Thomas E. Van Dyke et al.   Frontiers in Immunology

Eicosanoids

(2020) Bruce D. Hammock et al.   AMERICAN JOURNAL OF PATHOLOGY

ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

(2020) Elliott Lilley et al.   BRITISH JOURNAL OF PHARMACOLOGY

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

(2020) Nathalie Percie du Sert et al.   PLOS BIOLOGY

Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation

(2020) Brittney Ferguson et al.   Frontiers in Immunology

Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats

(2020) Juliana Maia Teixeira et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Carcinogenesis: Failure of resolution of inflammation?

(2020) Anna Fishbein et al.   PHARMACOLOGY & THERAPEUTICS

Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression

(2020) Anna Fishbein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Natural polymorphism of Ym1 regulates pneumonitis through alternative activation of macrophages

(2020) Wenhua Zhu et al.   Science Advances

Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes

(2020) Dmitry V. Chistyakov et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies

(2020) Kelsey Hildreth et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor

(2019) Allison Gartung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation

(2019) Sarah C. Starossom et al.   Nature Communications

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders

(2019) Kenji Hashimoto   Frontiers in Pharmacology

Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

(2019) Carla Alvarez et al.   Frontiers in Immunology

Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve?

(2019) Thomas E. Van Dyke et al.   PERIODONTOLOGY 2000

Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease

(2018) Alpdogan Kantarci et al.   EXPERIMENTAL NEUROLOGY

Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

(2018) Charles N. Serhan et al.   JOURNAL OF CLINICAL INVESTIGATION

Macrophages: The Bridge between Inflammation Resolution and Tissue Repair?

(2018) G.P. Garlet et al.   JOURNAL OF DENTAL RESEARCH

Resolving Macrophages Counter Osteolysis by Anabolic Actions on Bone Cells

(2018) A. Viniegra et al.   JOURNAL OF DENTAL RESEARCH

Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

(2018) M. H. Napimoga et al.   JOURNAL OF PERIODONTAL RESEARCH

Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions

(2018) Karim El Kholy et al.   Frontiers in Immunology

An experimental murine model to study periodontitis

(2018) Julie Marchesan et al.   Nature Protocols

Resolvin E1 attenuates murine psoriatic dermatitis

(2018) Yu Sawada et al.   Scientific Reports

Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis

(2017) Carlos Antonio Trindade-da-Silva et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases

(2017) Karen M. Wagner et al.   PHARMACOLOGY & THERAPEUTICS

Polymicrobial synergy and dysbiosis in inflammatory disease

(2015) Richard J. Lamont et al.   TRENDS IN MOLECULAR MEDICINE

Lipoxin Generation Is Related to Soluble Epoxide Hydrolase Activity in Severe Asthma

(2014) Emiko Ono et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pro-resolving lipid mediators are leads for resolution physiology

(2014) Charles N. Serhan   NATURE

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

(2012) J. Dalli et al.   BLOOD

Resolvin E2 Formation and Impact in Inflammation Resolution

(2012) S. F. Oh et al.   JOURNAL OF IMMUNOLOGY

Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst

(2011) Jianguo Xia et al.   Nature Protocols

Alternative Activation of Macrophages: Mechanism and Functions

(2010) Siamon Gordon et al.   IMMUNITY

Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids

(2010) Christophe Morisseau et al.   JOURNAL OF LIPID RESEARCH

1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure−Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain

(2010) Tristan E. Rose et al.   JOURNAL OF MEDICINAL CHEMISTRY

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

(2009) John D. Imig et al.   NATURE REVIEWS DRUG DISCOVERY

The dual role of IL-6-type cytokines on bone remodeling and bone tumors

(2008) Frédéric Blanchard et al.   CYTOKINE & GROWTH FACTOR REVIEWS